Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Jones

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Biomechanics (Bristol, Avon)|March 2, 2005
The gait initiation process in unilateral lower-limb amputees when stepping up and stepping down to a new levelS F Jones, P C Twigg, A J Scally, et al.
Australian Dental Journal|August 1, 1997
Orofacial granulomatosis: a diagnostic problem for the unwary and a management dilemma. Case reportsA M Clayden, C M Bleys, S F Jones, et al.
Anesthesiology|June 1, 1994
Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain. A double-blind, placebo-controlled, multicenter studyL B Ready, C R Brown, L H Stahlgren, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignanciesHoward A Burris, C D Kurkjian, L Hart, et al.
British Journal of Cancer|May 8, 2014
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignanciesA R Tan, A Dowlati, M N Stein, et al.
Investigational New Drugs|September 18, 1998
A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumorsN W Peacock, H A Burris, V Dieras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumorsA W Tolcher, J C Bendell, K P Papadopoulos, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Biomechanics (Bristol, Avon)|March 2, 2005
The gait initiation process in unilateral lower-limb amputees when stepping up and stepping down to a new levelS F Jones, P C Twigg, A J Scally, et al.
Australian Dental Journal|August 1, 1997
Orofacial granulomatosis: a diagnostic problem for the unwary and a management dilemma. Case reportsA M Clayden, C M Bleys, S F Jones, et al.
Anesthesiology|June 1, 1994
Evaluation of intravenous ketorolac administered by bolus or infusion for treatment of postoperative pain. A double-blind, placebo-controlled, multicenter studyL B Ready, C R Brown, L H Stahlgren, et al.
Cancer Chemotherapy and Pharmacology|June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignanciesHoward A Burris, C D Kurkjian, L Hart, et al.
British Journal of Cancer|May 8, 2014
Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignanciesA R Tan, A Dowlati, M N Stein, et al.
Investigational New Drugs|September 18, 1998
A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumorsN W Peacock, H A Burris, V Dieras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumorsA W Tolcher, J C Bendell, K P Papadopoulos, et al.
Pageof 3